Systematic review of pharmacological interventions for people with Lewy body dementia
(2022)
Journal Article
Objective: Lewy body dementia (LBD) is the second most common neurodegenerative dementia, and it causes earlier mortality and more morbidity than Alzheimer’s disease. Reviewing current evidence on its pharmacological management is essential for devel... Read More about Systematic review of pharmacological interventions for people with Lewy body dementia.